Higher Synovial Immunohistochemistry Reactivity of IL-17A, Dkk1, and TGF-β1 in Patients with Early Psoriatic Arthritis and Rheumatoid Arthritis Could Predict the Use of Biologics.
Jose A Pinto TasendeMercedes Fernández-MorenoIgnacio Rego PerezJ Carlos Fernandez-LopezNatividad Oreiro-VillarF Javier De Toro SantosFrancisco Javier BlancoPublished in: Biomedicines (2024)
Higher synovial immunohistochemistry reactivity of IL-17A, Dkk1, and TGF-β1 in patients with early psoriatic arthritis and rheumatoid arthritis may serve as potential indicators for predicting the necessity of utilising biologic treatments.